Introduction {#s1}
============

A significant proportion of embolic strokes of undetermined source (ESUS) are probably cardiogenic, but cardioembolic pathologies can elude standard assessments ([@B1]). Transesophageal echocardiography (TEE) is the gold standard for detection of emboligenic abnormalities, but it is not routinely performed in all patients for various reasons. Furthermore, the utility of routine TEE in cryptogenic stroke has been questioned, not least because of a low rate of atrial clot detection ([@B2]). A reason for this might be that remnant clots can dissolve shortly after stroke onset and prior to TEE; moreover, systemic thrombolysis can dissolve intracardiac thrombi ([@B3]).

An alternative method for detecting left atrial thrombi (and other cardiac pathology) is computed tomography (CT) ([@B4]), but ECG-triggered contrast-enhanced cardiac CT would unjustifiably delay thrombolysis and/or thrombectomy. However, relevant cardiac abnormalities, including left atrial clots, can be detected on non-cardiac CT ([@B5], [@B6]). Thus, when cerebral CT angiography (CCTA) is performed to detect large artery occlusion or stenosis within emergency stroke assessment, extending the scan range of the angiogram by several inches to include the heart seems feasible.

Scan range of emergency CCTA for acute stroke in elderly patients included the heart for a period of 3 months at our center. The potential for detecting intracardiac clots in patients with large artery occlusion or transient ischemic attack (TIA) and atrial fibrillation as well as ESUS was investigated.

Methods {#s2}
=======

A proof-of-principle study was conducted to assess the feasibility of performing an extended CCTA that includes the heart as well as its potential to detect atrial clots and other emboligenic pathology. At our center emergency CCTA is routinely performed when large artery occlusion or stenosis is suspected as a cause of acute stroke or TIA according to standard protocol as described elsewhere ([@B7]). During the period between 30.04.2018 and 03.08.2018, CT technicians had been instructed to set the lower limit of the scan range not to the aortic arch, but to the diaphragm, for any CCTA that was ordered for suspected stroke in patients ≥ 60 years. To increase the pretest probability of atrial thrombi we only analyzed data of acute stroke or TIA patients who had atrial fibrillation or ESUS ([Figure 1](#F1){ref-type="fig"}). Clinical data was collected retrospectively from electronic records of all consecutive patients during the study period who met inclusion criteria. ESUS diagnosis was assigned to patients who fulfilled all diagnostic criteria and had all required assessments ([@B1]). For the purpose of this study, findings from CCTA proximal of the aortic arch were not considered for ESUS status. The effective radiation dose was estimated by multiplying the automatically calculated dose length product (DLP) by a standard conversion factor of 0.014 mSv (mGy·cm)^−1^ ([@B8]). This study was approved by the ethics committee of the medical faculty of the Ruhr University Bochum.

![Flow chart showing the selection of the study population.](fneur-10-00349-g0001){#F1}

Results {#s3}
=======

A total of 59 patients underwent emergency CCTA ([Figure 2A](#F2){ref-type="fig"}) for suspected stroke, of which 44 received the final diagnosis ischemic stroke. There were 17 patients who had ischemic stroke or TIA and known or newly diagnosed atrial fibrillation ([Table 1](#T1){ref-type="table"}; mean age: 77.5 years, standard deviation: 8.4 years; 53% female). As hypothesized, intracardiac thrombi could be visualized: once in an artificially occluded left atrial appendage, once around a pacemaker lead in the right atrium, and once in the left atrial appendage ([Figures 2B,C](#F2){ref-type="fig"}). Four patients were classified as ESUS ([Table 2](#T2){ref-type="table"}; mean age 80 years, standard deviation 2.7 years; 25% female). Irregular and ulcerating plaques were found in the proximal ascending aorta of two of these patients ([Figure 2D](#F2){ref-type="fig"}).

![**(A)** Scout-view showing scan range of conventional (1,2) and extended (1--4) angiography; (3) corresponds to panel **(B)**. Axial CT images: **(B)** thrombotic material in appendage of left atrium (LA) in patient 15; **(C)** thrombus around pacemaker lead in right atrium (RA) in patient 17; **(D)** ulcerating plaque in ascending aorta (AAo) in patient with ESUS.](fneur-10-00349-g0002){#F2}

###### 

Patients with ischemic stroke and atrial fibrillation.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
       **Stroke diagnosis**             **Atrial fibrillation**   **Anticoagulation**                                      **Cardiac pathology in CT angiogram**
  ---- -------------------------------- ------------------------- -------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
  1    RICA and RMCA tandem occlusion   Known                     Yes\                                                     Coronary atherosclerosis, valvular calcification
                                                                  (dabigatran 2 × 110 mg)                                  

  2    BA occlusion                     Newly diagnosed           No                                                       Coronary atherosclerosis

  3    LPCA occlusion                   Known                     No                                                       Thrombus in occluded left atrial appendage, coronary atherosclerosis

  4    Recurring TIA                    Known                     No\                                                      Coronary atherosclerosis, evidence of cardiac bypass surgery
                                                                  (non-adherence)                                          

  5    RPCA branch occlusion            Newly diagnosed           No                                                       Coronary atherosclerosis

  6    LMCA branch occlusion            Newly diagnosed           No                                                       None

  7    RMCA occlusion                   Known                     Yes\                                                     Right atrial enlargement, coronary atherosclerosis
                                                                  (heparin, PTT 35.8 s)[^\*^](#TN1){ref-type="table-fn"}   

  8    RMCA occlusion                   Known                     No\                                                      Coronary atherosclerosis, valvular calcification
                                                                  (paused for surgery)                                     

  9    TIA                              Known                     Yes\                                                     None
                                                                  (phenprocoumon, INR 1.98)                                

  10   RICA occlusion                   Known                     No                                                       Cardiomegaly, coronary atherosclerosis, valvular calcification

  11   RMCA branch occlusion            Newly diagnosed           No                                                       Coronary atherosclerosis

  12   RMCA infarctions                 Known                     No\                                                      Coronary atherosclerosis
                                                                  (non-adherence)                                          

  13   RMCA occlusion                   Known                     No\                                                      Coronary atherosclerosis
                                                                  (non-adherence)                                          

  14   RICA occlusion                   Known                     No                                                       Coronary atherosclerosis, valvular calcification

  15   LMCA branch occlusion            Known                     No                                                       Thrombus in left atrial appendage, coronary atherosclerosis

  16   TIA                              Known                     Yes\                                                     Coronary atherosclerosis, valvular calcification
                                                                  (apixaban 2 × 5 mg)                                      

  17   TIA                              Known                     Yes\                                                     Thrombus around pacemaker lead in right atrium, cardiomegaly, coronary atherosclerosis, valvular calcification
                                                                  (apixaban 2 × 2.5 mg) [^†^](#TN2){ref-type="table-fn"}   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*BA, basillary artery; INR, international Normalized Ratio; LMCA, left middle cerebral artery; LPCA, left posterior cerebral artery; PTT, partial thromboplastin time; RICA, right internal carotid artery; RMCA, right middle cerebral artery; RPCA, right posterior cerebral artery; TIA, transient ischemic attack*.

*Periprocedural heparin during transcatheter mitral valve repair*.

*Renal clearance ≥ 30 ml/min, serum creatinine \< 1,5 mg/dl, and weight \> 60 kg; half-dose due to history of bleeding, presumably insufficient/ineffective*.

###### 

Patients with embolic stroke of undetermined source (ESUS)[^\*^](#TN3){ref-type="table-fn"}.

       **Stroke diagnosis**    **Cardiac pathology in CT angiogram**                                                                                 **Echocardiography**
  ---- ----------------------- --------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------
  18   RMCA branch occlusion   Atheromatosis with irregular plaques in proximal ascending aorta, coronary atherosclerosis, valvular calcification    TTE: mildly dilated left atrium
                                                                                                                                                     TEE: ulcerating aortic plaques with floating parts, mildly dilated left atrium, persistent foramen ovale
  19   RPCA occlusion          Atheromatosis with ulcerating plaques in proximal ascending aorta, coronary atherosclerosis, valvular calcification   TTE: mildly dilated left atrium
  20   LMCA occlusion          Coronary atherosclerosis, valvular calcification                                                                      TTE: mildly dilated left atrium, aortic sclerosis
  21   LMCA branch occlusion   Coronary atherosclerosis                                                                                              TTE and TEE: mildly dilated left atrium

*LMCA, left middle cerebral artery; RMCA, right middle cerebral artery; RPCA, right posterior cerebral artery; TEE, transesophageal echocardiography; TTE, transthoracic echocardiogram*.

*For the purpose of this study findings first identified on CT angiography proximal of the aortic arch were disregarded for ESUS criteria*.

Median DLP for all 44 ischemic stroke patients was 358 mGy·cm (interquartile range, 305--549 mGy·cm); corresponding radiation doses were thus 5.01 mSv (interquartile range, 4.27--7.69 mSv).

Discussion {#s4}
==========

Our results demonstrate that co-imaging of cardiac structures within emergency CCTA in elderly patients with ischemic stroke or TIA and atrial fibrillation or ESUS can indeed visualize intracardiac clots before thrombolytic treatment, as well as other emboligenic pathologies such as ulcerating plaques of the ascending aorta.

The main advantage of cardiac imaging within routine CCTA compared to dedicated ECG-gated cardiac CT is the minimal delay of only a few extra seconds, and the sparing of additional contrast agent. A potential disadvantage is lower image quality due to heart movement artifacts and variable contrast filling since bolus timing is optimized for cerebral arterial visualization ([@B9]). However, studies suggest that ECG-gating does not markedly improve image quality of the ascending aorta ([@B10]) or the left atrium ([@B11]). Image quality in this study was adequate in most cases, though larger samples with control imaging would be needed to quantify differences. While TEE remains the gold standard for intracardiac clot detection, it requires specialized expertise and is time-consuming. Performing it in an emergency setting before thrombolysis would introduce an unjustifiable time delay.

The additional radiation exposure during cardiac imaging added to CCTA has to be considered. In our study the median DLP and estimated radiation dose for the entire extended CCTA were less than average for cardiac CT angiography ([@B8]). The lifetime risk of radiation-induced fatal cancer for this procedure is \<0.05%, added to an average background risk of 21% ([@B12]). Although our study design did not allow calculating the added radiation exposure in extended CCTA compared to routine CCTA, the added risk would naturally be even lower. Especially in an elderly population, radiation-associated risks thus can be considered negligible. Moreover, comprehensive risk analysis should also consider periprocedural risks of TEE \[0.02% for serious complications ([@B2])\] and the risk of cryptogenic stroke recurrence (3--6%/year) ([@B1]).

Our study design does not allow estimations of the diagnostic yield of extended CCTA, pre-treatment prevalence of remnant left atrial clots, or direct comparisons with other methods. However, our findings serve as a proof of principle: intracardiac clots can be detected on extended emergency CCTA before they are potentially dissolved by thrombolysis or flushed into the circulation. We looked at patients with known atrial fibrillation to increase pretest probability for cardiac thrombi. However, the biggest clinical benefit of this method would be expected in patients with cryptogenic stroke, where detecting a cardiac thrombus has profound implications for acute treatment (early anticoagulation, follow-up imaging) and secondary prevention (long-term anticoagulation). Prospective multi-center studies should explore this idea in the future. In the long run, a "one-stop shop" multimodal CT program could be developed to optimize emergency stroke diagnostics.
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